# Biological role of Semaphorin 6D in the proliferation, migration and invasion of gastric cancer

**Authors:** Huan Zhou, Guang Chen

PMC · DOI: 10.4314/ahs.v24i3.21 · African Health Sciences · 2024-09-01

## TL;DR

This study shows that Semaphorin 6D influences the growth and spread of gastric cancer by affecting key signaling pathways.

## Contribution

The study reveals a novel role of SEMA6D in gastric cancer progression through ERK and PI3K/AKT/mTOR pathways.

## Key findings

- SEMA6D knockdown reduced the activation of ERK and PI3K/AKT/mTOR pathways in gastric cancer cells.
- Lower SEMA6D levels were associated with decreased cell migration and invasion in vitro.
- SEMA6D expression is linked to the biological behavior of gastric cancer cells.

## Abstract

To analyse how Semaphorin 6D (SEMA6D) expression and extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signal pathways are activated and how they influence gastric cancer proliferation, migration, and invasion.

SEMA6D expression was knocked down in human gastric cancer cells using RNA interference technology. In vitro assays were used to analyse how SEMA6D knockdown affects clone formation, migration, and invasion. ERK and PI3K/AKT/mTOR signaling pathway related proteins were detected by immunoblotting.

In the si-NC group, Sema6D protein levels were higher than those in the si-1 and si-2 groups after knockdown of Sema6D, while in the si-1 group, Sema6D protein levels were higher than those in the si-2 group (P<0.05). P-PI3K, ERK/p-ERK, AKT/p-AKT, and mTOR/p-mTOR levels in the si-NC group were significantly higher than those in the si-1 and si-2 groups after knockdown of Sema6D (P < 0.05). It was found that scratch healing rate of SGC-7901 cells in si-NC group was higher than that in si-1 and si-2 groups, and the difference was statistically significant (P < 0.05).

SEMA6D expression level can affect the biological behavior of gastric cancer cells.

## Linked entities

- **Genes:** SEMA6D (semaphorin 6D) [NCBI Gene 80031]
- **Proteins:** EPHB2 (EPH receptor B2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), Akt (Akt kinase), SEMA6D (semaphorin 6D)
- **Diseases:** gastric cancer (MONDO:0001056)

## Full-text entities

- **Genes:** PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, SEMA6D (semaphorin 6D) [NCBI Gene 80031], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}
- **Diseases:** gastric cancer (MESH:D013274)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** SGC-7901 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0520)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12327128/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12327128/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12327128/full.md

---
Source: https://tomesphere.com/paper/PMC12327128